OBJECTIVE: The purpose of this study was to examine the effects of specific personality disorder comorbidity on the course of major depressive disorder in a nationally representative sample. METHOD: Data were drawn from 1,996 participants in a national survey. Participants who met criteria for major depressive disorder at baseline in face-to-face interviews (in 2001-2002) were reinterviewed 3 years later (in 2004-2005) to determine persistence and recurrence. Predictors included all DSM-IV personality disorders. Control variables included demographic characteristics, other axis I disorders, family and treatment histories, and previously established predictors of the course of major depressive disorder. RESULTS: A total of 15.1% of participants had persistent major depressive disorder, and 7.3% of those who remitted had a recurrence. Univariate analyses indicated that avoidant, borderline, histrionic, paranoid, schizoid, and schizotypal personality disorders all elevated the risk for persistence. With axis I comorbidity controlled, all personality disorders except histrionic personality disorder remained significant. With all other personality disorders controlled, borderline and schizotypal disorders remained significant predictors. In final, multivariate analyses that controlled for age at onset of major depressive disorder, the number of previous episodes, duration of the current episode, family history, and treatment, borderline personality disorder remained a robust predictor of major depressive disorder persistence. Neither personality disorders nor other clinical variables predicted recurrence. CONCLUSIONS: In this nationally representative sample of adults with major depressive disorder, borderline personality disorder robustly predicted persistence, a finding that converges with recent clinical studies. Personality psychopathology, particularly borderline personality disorder, should be assessed in all patients with major depressive disorder, considered in prognosis, and addressed in treatment.
OBJECTIVE: The purpose of this study was to examine the effects of specific personality disorder comorbidity on the course of major depressive disorder in a nationally representative sample. METHOD: Data were drawn from 1,996 participants in a national survey. Participants who met criteria for major depressive disorder at baseline in face-to-face interviews (in 2001-2002) were reinterviewed 3 years later (in 2004-2005) to determine persistence and recurrence. Predictors included all DSM-IV personality disorders. Control variables included demographic characteristics, other axis I disorders, family and treatment histories, and previously established predictors of the course of major depressive disorder. RESULTS: A total of 15.1% of participants had persistent major depressive disorder, and 7.3% of those who remitted had a recurrence. Univariate analyses indicated that avoidant, borderline, histrionic, paranoid, schizoid, and schizotypal personality disorders all elevated the risk for persistence. With axis I comorbidity controlled, all personality disorders except histrionic personality disorder remained significant. With all other personality disorders controlled, borderline and schizotypal disorders remained significant predictors. In final, multivariate analyses that controlled for age at onset of major depressive disorder, the number of previous episodes, duration of the current episode, family history, and treatment, borderline personality disorder remained a robust predictor of major depressive disorder persistence. Neither personality disorders nor other clinical variables predicted recurrence. CONCLUSIONS: In this nationally representative sample of adults with major depressive disorder, borderline personality disorder robustly predicted persistence, a finding that converges with recent clinical studies. Personality psychopathology, particularly borderline personality disorder, should be assessed in all patients with major depressive disorder, considered in prognosis, and addressed in treatment.
Authors: J G Gunderson; M T Shea; A E Skodol; T H McGlashan; L C Morey; R L Stout; M C Zanarini; C M Grilo; J M Oldham; M B Keller Journal: J Pers Disord Date: 2000
Authors: D A Solomon; M B Keller; A C Leon; T I Mueller; M T Shea; M Warshaw; J D Maser; W Coryell; J Endicott Journal: Arch Gen Psychiatry Date: 1997-11
Authors: Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering Journal: Drug Alcohol Depend Date: 2003-07-20 Impact factor: 4.492
Authors: Jay C Fournier; Robert J DeRubeis; Richard C Shelton; Robert Gallop; Jay D Amsterdam; Steven D Hollon Journal: Br J Psychiatry Date: 2008-02 Impact factor: 9.319
Authors: Frederick S Stinson; Deborah A Dawson; Risë B Goldstein; S Patricia Chou; Boji Huang; Sharon M Smith; W June Ruan; Attila J Pulay; Tulshi D Saha; Roger P Pickering; Bridget F Grant Journal: J Clin Psychiatry Date: 2008-07 Impact factor: 4.384
Authors: Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant Journal: Arch Gen Psychiatry Date: 2011-11
Authors: Jennifer C Elliott; Malka Stohl; Melanie M Wall; Katherine M Keyes; Renee D Goodwin; Andrew E Skodol; Robert F Krueger; Bridget F Grant; Deborah S Hasin Journal: Addiction Date: 2014-02-16 Impact factor: 6.526
Authors: Alvaro Vergés; Matt G Kushner; Kristina M Jackson; Kathleen K Bucholz; Timothy J Trull; Sean P Lane; Kenneth J Sher Journal: J Anxiety Disord Date: 2013-10-14
Authors: Matthew C Lohman; Karen L Whiteman; Frank E Yeomans; Sheila A Cherico; Winifred R Christ Journal: Psychiatr Serv Date: 2016-10-03 Impact factor: 3.084